Intraoperative irradiation for locally advanced primary and recurrent rectal cancer

L. L. Gunderson, B. G. Wolff, S. Cha, M. G. Haddock, S. E. Schild, R. M. Devine, J. A. Martenson

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Encouraging trends exist for improvements in local control and possibly survival when IOERT is added to standard treatment (external irradiation, chemotherapy, resection) for locally advanced primary and recurrent rectal cancers. Disease control within the IOERT and external beam fields is decreased, however, when gross total resection cannot be accomplished. Therefore, 5-Fluorouracil (± other drugs) should consistently be considered during EBRT, and clinical trials should be undertaken to evaluate dose modifiers in conjunction with IOERT (sensitizers, hyperthermia, etc.). Since the incidence of distant metastases is excessive in patients with locally advanced primary and recurrent rectal cancers, maintenance, as well as concomitant chemotherapy, should be evaluated as a component of the aggressive treatment approaches discussed in this article.

Original languageEnglish (US)
Pages (from-to)93-105
Number of pages13
JournalProblems in General Surgery
Volume12
Issue number4
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Intraoperative irradiation for locally advanced primary and recurrent rectal cancer'. Together they form a unique fingerprint.

  • Cite this

    Gunderson, L. L., Wolff, B. G., Cha, S., Haddock, M. G., Schild, S. E., Devine, R. M., & Martenson, J. A. (1996). Intraoperative irradiation for locally advanced primary and recurrent rectal cancer. Problems in General Surgery, 12(4), 93-105.